{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:20:21Z","timestamp":1790882421434,"version":"4.1.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>We aimed to characterize the clinical and radiological features, and outcomes, of a large cohort of hypertrophic pachymeningitis (HP) patients from a single centre.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a retrospective study at a tertiary referral centre, encompassing patients diagnosed with HP between 2003 and 2022. The diagnosis of HP relied on the identification of thickening of the dura mater via MRI of the brain or spine.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We included 74 patients, with a mean age of 43.6\u2009\u00b1\u200914.2\u2009years, of whom 37 (50%) were male. Among the 74, 32 (43.2%) had an immune-mediated origin, including 21 with granulomatosis with polyangiitis (GPA) (predominantly PR3-ANCA positive), four with SLE, three with IgG4-related disease, three with idiopathic HP, and one with RA. Non-immune-mediated HP accounted for 45 cases (56.8%). Within this category, 21 (28.4%) were infectious cases, with 14 having Mycobacterium tuberculosis infection (TB-HP), and 21 (28.4%) having malignancy-associated HP. The clinical and MRI characteristics exhibited variations among the four etiological groups. Hypoglycorrhachia was primarily observed in infectious HP and malignancy-associated HP. Immune-mediated HP was associated with a peripheral pattern of contrast enhancement and the Eiffel-by-night sign. MRI features strongly indicative of TB-HP included leptomeningeal involvement, brain parenchymal lesions, and arterial stroke. MPO-ANCA GPA was associated with a higher prevalence of spinal HP.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusios<\/jats:title>\n                  <jats:p>Within our cohort, GPA and Mycobacterium tuberculosis emerged as the predominant causes of HP. We identified significant disparities in clinical and radiological features among the various etiologies, which could have implications for diagnosis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae293","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T19:39:02Z","timestamp":1715974742000},"page":"1292-1301","source":"Crossref","is-referenced-by-count":5,"title":["Distinct features of ANCA-associated hypertrophic pachymeningitis compared with other etiologies: findings from a study of 74 patients"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7911-1269","authenticated-orcid":false,"given":"Eduardo","family":"Mart\u00edn-Nares","sequence":"first","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n , Mexico City,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Griselda","family":"Romero-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Department of Radiology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n , Mexico City,","place":["Mexico"]},{"name":"Department of Radiology, University of British Columbia , Vancouver,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin Ulises","family":"Cortez-Dom\u00ednguez","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n , Mexico City,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian Guadalupe","family":"Cano-Cruz","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n , Mexico City,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4001-3995","authenticated-orcid":false,"given":"Andrea","family":"Hinojosa-Azaola","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n , Mexico City,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,17]]},"reference":[{"key":"2025030500190155200_keae293-B1","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1097\/00006123-199912000-00014","article-title":"Idiopathic hypertrophic cranial pachymeningitis: clinicoradiological spectrum and therapeutic options","volume":"45","author":"Hatano","year":"1999","journal-title":"Neurosurgery"},{"key":"2025030500190155200_keae293-B2","doi-asserted-by":"crossref","first-page":"e11413","DOI":"10.1097\/MD.0000000000011413","article-title":"Characteristics, outcome and treatments with cranial pachymeningitis: a multicenter French retrospective study of 60 patients","volume":"97","author":"Mekinian","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"2025030500190155200_keae293-B3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/jnnp-2013-306410","article-title":"A nationwide survey of hypertrophic pachymeningitis in Japan","volume":"85","author":"Yonekawa","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2025030500190155200_keae293-B4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10072-018-3689-3","article-title":"Clinical features of hypertrophic pachymeningitis in a center survey","volume":"40","author":"Ca\u00e7\u00e3o","year":"2019","journal-title":"Neurol Sci"},{"key":"2025030500190155200_keae293-B5","doi-asserted-by":"crossref","first-page":"565088","DOI":"10.3389\/fneur.2020.565088","article-title":"Hypertrophic pachymeningitis in a Southern Chinese population: a retrospective study","volume":"11","author":"Xiao","year":"2020","journal-title":"Front Neurol"},{"key":"2025030500190155200_keae293-B6","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/brain\/awt314","article-title":"Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody","volume":"137","author":"Yokoseki","year":"2014","journal-title":"Brain"},{"key":"2025030500190155200_keae293-B7","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13075-022-02898-4","article-title":"Hypertrophic pachymeningitis in ANCA-associated vasculitis: a cross-sectional and multi-institutional study in Japan (J-CANVAS)","volume":"24","author":"Shimojima","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2025030500190155200_keae293-B8","doi-asserted-by":"crossref","first-page":"103338","DOI":"10.1016\/j.autrev.2023.103338","article-title":"Hypertrophic pachymeningitis in ANCA-associated vasculitis: clinical and immunopathological features and insights","volume":"22","author":"Shimojima","year":"2023","journal-title":"Autoimmun Rev"},{"key":"2025030500190155200_keae293-B9","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/rheumatology\/keu336","article-title":"Central nervous system involvement of granulomatosis with polyangiitis: clinical-radiological presentation distinguishes different outcomes","volume":"54","author":"De Luna","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"2025030500190155200_keae293-B10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13075-023-03239-9","article-title":"Clinical characteristics of hypertrophic cranial pachymeningitis in granulomatosis with polyangiitis: a retrospective single-center study in China","volume":"26","author":"Chen","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"2025030500190155200_keae293-B11","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1016\/j.acra.2023.01.017","article-title":"Immune-mediated hypertrophic pachymeningitis and its mimickers: magnetic resonance imaging findings","volume":"30","author":"Matias","year":"2023","journal-title":"Acad Radiol"},{"key":"2025030500190155200_keae293-B12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2025030500190155200_keae293-B13","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2025030500190155200_keae293-B14","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1136\/annrheumdis-2020-218615","article-title":"European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"81","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2025030500190155200_keae293-B15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease","volume":"79","author":"Wallace","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2025030500190155200_keae293-B16","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2025030500190155200_keae293-B17","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5","article-title":"A disease-specific activity index for Wegener\u2019s granulomatosis: modification of the Birmingham Vasculitis Activity Score","volume":"44","author":"Stone","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2025030500190155200_keae293-B18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/art.1780400222","article-title":"Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides","volume":"40","author":"Exley","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2025030500190155200_keae293-B19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/annrheumdis-2021-221795","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis","volume":"81","author":"Robson","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2025030500190155200_keae293-B20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jns.2015.02.013","article-title":"Clinico-radiological spectrum and outcome in idiopathic hypertrophic pachymeningitis","volume":"350","author":"Dash","year":"2015","journal-title":"J Neurol Sci"},{"key":"2025030500190155200_keae293-B21","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4103\/aian.aian_561_23","article-title":"The spectrum of intracranial hypertrophic pachymeningitis at an Eastern Indian Tertiary care center","volume":"26","author":"Das","year":"2023","journal-title":"Ann Indian Acad Neurol"},{"key":"2025030500190155200_keae293-B22","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1177\/0961203319862867","article-title":"SLE pachymeningitis and multiple cranial nerve palsies: a case report and review of the literature","volume":"28","author":"John","year":"2019","journal-title":"Lupus"},{"key":"2025030500190155200_keae293-B23","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s10067-018-4372-z","article-title":"Incidence and risk factors of new-onset hypertrophic pachymeningitis in patients with anti-neutrophil antibody-associated vasculitis: using logistic regression and classification tree analysis","volume":"38","author":"Imafuku","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2025030500190155200_keae293-B24","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s00415-017-8416-0","article-title":"Characteristics of hypertrophic pachymeningitis in patients with granulomatosis with polyangiitis","volume":"264","author":"Choi","year":"2017","journal-title":"J Neurol"},{"key":"2025030500190155200_keae293-B25","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/197140090702000211","article-title":"\u2018Eiffel-by-Night\u2019: a new MR sign demonstrating reactivation in idiopathic hypertrophic pachymeningitis","volume":"20","author":"Thomas","year":"2007","journal-title":"Neuroradiol J"},{"key":"2025030500190155200_keae293-B26","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrneurol.2017.120","article-title":"Tuberculous meningitis","volume":"13","author":"Wilkinson","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"2025030500190155200_keae293-B27","doi-asserted-by":"crossref","first-page":"e0241974","DOI":"10.1371\/journal.pone.0241974","article-title":"Brain MRI findings in relation to clinical characteristics and outcome of tuberculous meningitis","volume":"15","author":"Dian","year":"2020","journal-title":"PLoS One"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae293\/58231092\/keae293.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/3\/1292\/58231092\/keae293.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/3\/1292\/58231092\/keae293.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:23:03Z","timestamp":1741134183000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/3\/1292\/7676136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,17]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,5,17]]},"published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae293","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,5,17]]}}}